danofloxacin has been researched along with Pleuropneumonia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friis, C; Lauritzen, B; Lykkesfeldt, J | 1 |
| Angen, Ø; Friis, C; Lauritzen, B; Lykkesfeldt, J; Nielsen, JP; Skaanild, MT | 1 |
| Chae, C; Cheon, DS; Cho, WS; Choi, C; Kim, B; Kim, J; Kwon, D; Min, K | 1 |
3 other study(ies) available for danofloxacin and Pleuropneumonia
| Article | Year |
|---|---|
Evaluation of a single dose versus a divided dose regimen of danofloxacin in treatment of Actinobacillus pleuropneumoniae infection in pigs.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Infective Agents; Area Under Curve; Ascorbic Acid; Body Temperature; C-Reactive Protein; Fluoroquinolones; Injections, Intravenous; Leukocyte Count; Male; Microbial Sensitivity Tests; Pleuropneumonia; Random Allocation; Swine; Swine Diseases; Zinc | 2003 |
Putative biomarkers for evaluating antibiotic treatment: an experimental model of porcine Actinobacillus pleuropneumoniae infection.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; alpha-Tocopherol; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ascorbic Acid; Biomarkers; C-Reactive Protein; Diterpenes; Fluoroquinolones; Haptoglobins; Interleukin-6; Leukocyte Count; Lung; Macrolides; Male; Pleuropneumonia; Random Allocation; Swine; Swine Diseases; Zinc | 2003 |
Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Korea using new standardized procedures.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Infective Agents; Cephalosporins; Drug Resistance, Microbial; Fluoroquinolones; Korea; Microbial Sensitivity Tests; Penicillins; Pleuropneumonia; Swine; Swine Diseases | 2001 |